Brighter and UAE Ministry of Health and Prevention will showcase Actiste at Arab Health 2019.
The Ministry of Health and Prevention (MOHAP) of the United Arab Emirates has invited Brighter to demonstrate Brighter’s unique remote diabetes monitoring and treatment solution, Actiste® Diabetes Management as a Service, in the Ministry’s booth at Arab Health 2019, to be held January 28-31 in Dubai.
MOHAP’s mission is to enhance community health across the UAE by providing comprehensive, innovative, and fair healthcare services, and performing its role as a regulator and supervisor of the nation’s healthcare sector through a modern and integrated health legislative system.
“It is a great honor to be invited by MOHAP and we look forward to joining them at this world-class exhibition. The Ministry provides the citizens and residents of the UAE with an effective and sustainable healthcare system, and we are very glad that the Ministry wants to showcase Actiste in this context,” says Hamza Moftah, Deputy Managing Director UAE, Brighter.
Arab Health is one of the largest gatherings of healthcare companies, technology, products and services in the world. Taking place from 28 - 31 January 2019, the event is expected to welcome more than 4,150 exhibiting companies and 84,500 attendees from 160+ countries, as well as 4,500 medical delegates to its concurrent (Continuing Medical Education) CME symposium, the Arab Health Congress. Earlier, Arab Health commented that innovation is driving the healthcare industry forward and advances in technologies are creating vast new possibilities and opportunities for the UAE healthcare sector, thereby placing an emphasis on the innovation theme this year.
“Arab Health is a great opportunity to demonstrate the award winning Actiste to the world and to make an impact on the global healthcare industry. The support from MOHAP means a lot to us and confirms that we have created a sought-after solution meeting very high standards. I expect a great deal of attention from investors and potential customers from all over the world during this event,” says Truls Sjöstedt, Brighter’s CEO and founder.
For further information, please contact:
Truls Sjöstedt, CEO
Phone: +46 709 73 46 00
Email: truls.sjostedt@brighter.se
Henrik Norström, COO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
About Actiste.
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent.
Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. https://actiste.com/
About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. https://brighter.se/
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.